Full name
NASZA APTEKA IZABELA GÓRAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
73 - Advertising, market research and public relations
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | -0,1 | -0,2 | -75,4 |
Gross profit (loss) | -0,1 | -0,1 | -0,2 | -71,8 |
EBITDA | -0,1 | -0,1 | -0,2 | -89,4 |
Short time liabilities | 0,3 | 0,4 | 0,5 | 20,6 |
Other operating costs | 0 | 0 | 0 | 25,7 |
Equity capital | -0,2 | -0,4 | -0,6 | -59 |
Operating profit (EBIT) | -0,1 | -0,1 | -0,2 | -71,9 |
Assets | 0,7 | 0,8 | 0,9 | 9,7 |
Net profit (loss) | -0,1 | -0,1 | -0,2 | -71,8 |
Cash | 0 | 0,1 | 0,1 | 6 |
Net income from sale | 2,3 | 2,6 | 3,1 | 16,9 |
Liabilities and provisions for liabilities | 0,9 | 0 | 1,4 | -∞ |
Working assets | 0,6 | 0,7 | 0,8 | 14,1 |
Other income costs | 0 | 0 | 0 | 14 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 45,9 | 34,4 | 37,1 | 2,7 |
Equity capital to total assets | -35,2 | -46,6 | -67,5 | -20,9 |
Gross profit margin | -4,8 | -4,8 | -7 | -2,2 |
EBITDA Margin | -3,7 | -3,8 | -6,2 | -2,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 50 | 62 | 64 | 2 |
Current financial liquidity indicator | 1.8509371280670166 | 1.602575421333313 | 1.5152477025985718 | -0,1 |
Net dept to EBITDA | -6.531171798706055 | -6.273369312286377 | -4.3349714279174805 | 2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane